Risk of intestinal lymphoma in undiagnosed coeliac disease: Results from a registered population with different coeliac disease prevalence

Digestive and Liver Disease

Volumn 44, Issue 9, 2012, Pages 743-747

  Elli, Luca ^a   Contiero, Paolo ^b   Tagliabue, Giovanna ^b   Tomba, Carolina ^a,c   Bardella, Maria Teresa ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Coeliac disease; Enteropathy associated T cell lymphoma; Gastrointestinal lymphoma; Gluten free diet; Intestinal lymphoma

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CELIAC DISEASE; FEMALE; HUMAN; INTESTINE LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; CELIAC DISEASE; ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA; FEMALE; HUMANS; INCIDENCE; INTESTINAL NEOPLASMS; ITALY; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PREVALENCE;

EID: 84864410144     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.04.020     Document Type: Article

References (37)

1. van der Windt D.A., Jellema P., Mulder C.J., et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA 2010, 303:1738-1746.
2. Elli L., Bergamini C.M., Bardella M.T., et al. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver. Digestive and Liver Disease 2009, 41:541-550.
3. Holmes G.K., Prior P., Lane M.R., et al. Malignancy in coeliac disease-effect of a gluten free diet. Gut 1989, 30:333-338.
4. Silano M., Volta U., Vincenzi A.D., et al. Effect of a gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease. Digestive Diseases and Sciences 2008, 53:972-976.
5. Elli L., Bardella M.T. Motility disorders in patients with celiac disease. Scandinavian Journal of Gastroenterology 2005, 40:743-749.
6. Menardo G., Brizzolara R., Bonassi S., et al. Population screening for coeliac disease in a low prevalence area in Italy. Scandinavian Journal of Gastroenterology 2006, 41:1414-1420.
7. Tommasini A., Not T., Kiren V., et al. Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Archives of Disease in Childhood 2004, 89:512-515.
8. Smedby K.E., Akerman M., Hildebrand H., et al. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 2005, 54:54-59.
9. Smedby K.E., Baecklund E., Askling J. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiology, Biomarkers and Prevention 2006, 15:2069-2077.
10. Askling J., Linet M., Gridley G., et al. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 2002, 123:1428-1435.
11. Catassi C., Fabiani E., Corrao G., et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002, 287:1413-1419.
12. Delco F., El-Serag H.B., Sonnenberg A. Celiac sprue among US military veterans: associated disorders and clinical manifestations. Digestive Diseases and Sciences 1999, 44:966-972.
13. Corrao G., Corazza G.R., Bagnardi V., et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001, 358:356-361.
14. Card T.R., West J., Holmes G.K. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Alimentary Pharmacology and Therapeutics 2004, 20:769-775.
15. Cardinali C., Degl'innocenti D., Caproni M., et al. Is the search for serum antibodies to gliadin, endomysium and tissue transglutaminase meaningful in psoriatic patients? Relationship between the pathogenesis of psoriasis and coeliac disease. British Journal of Dermatology 2002, 147:187-188.
16. Gao Y., Kristinsson S.Y., Goldin L.R., et al. Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association. Gastroenterology 2009, 136:91-98.
17. Green P.H.R., Stavropoulos S.N., Panagi S.G., et al. Characteristics of adult celiac disease in the USA: results of a national survey. American Journal of Gastroenterology 2001, 96:126-131.
18. Elfstrom P., Montgomery S.M., Kampe O., et al. Risk of thyroid disease in individuals with celiac disease. Journal of Clinical Endocrinology and Metabolism 2008, 93:3915-3921.
19. Ludvigsson J.F., Montgomery S.M., Ekbom A., et al. Small-intestinal histopathology and mortality risk in celiac disease. JAMA 2009, 302:1171-1178.
20. Molberg O., Solheim Flaete N., Jensen T., et al. Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology 2003, 125:337-344.
21. Cil T., Altintas A., Isikdogan A., et al. Screening for Celiac disease in Hodgkin and non-Hodgkin lymphoma patients. Turkish Journal of Gastroenterology 2009, 20:87-92.
22. Freeman H.J. Adult celiac disease in the elderly. World Journal of Gastroenterology 2008, 14:6911-6914.
23. Contiero P., Tittarelli A., Maghini A., et al. Comparison with manual registration reveals satisfactory completeness and efficiency of a computerized cancer registration system. Journal of Biomedical Informatics 2008, 41:24-32.
24. Marsh M.N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992, 102:330-354.
25. Mearin M.L., Catassi C., Brousse N., et al. European multi-centre study on coeliac disease and non-Hodgkin lymphoma. European Journal of Gastroenterology and Hepatology 2006, 18:187-194.
26. Farre C., Domingo-Domenech E., Font R., et al. Celiac disease and lymphoma risk: a multicentric case-control study in Spain. Digestive Diseases and Sciences 2004, 49:408-412.
27. Korponay-Szabo I.R., Szabados K., Pusztai J., et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ (Clinical Research Ed.) 2007, 335:1244-1247.
28. Dube C., Rostom A., Sy R., et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005, 128:S57-S67.
29. Schapira M., Maisin J.M., Ghilain J.M., et al. Epidemiology of coeliac disease. Acta Gastroenterologica Belgica 2003, 66:234-236.
30. McLoughlin R., Sebastian S.S., Qasim A., et al. Coeliac disease in Europe. Alimentary Pharmacology and Therapeutics 2003, 18(Suppl. 3):45-48.
31. Schuppan D., Junker Y., Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009, 137:1912-1933.
32. Collin P., Reunala T., Pukkala E., et al. Coeliac disease-associated disorders and survival. Gut 1994, 35:1215-1218.
33. Godfrey J.D., Brantner T.L., Brinjikji W., et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 2005, 139:763-769.
34. Tio M., Cox M.R., Eslick G.D. Meta-analysis: coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy. Alimentary Pharmacology and Therapeutics 2012, 35:540-551.
35. Lohi S., Maki M., Rissanen H., et al. Prognosis of unrecognized coeliac disease as regards mortality: a population-based cohort study. Annals of Medicine 2009, 41:508-515.
36. Olen O., Askling J., Ludvigsson J.F., et al. Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype. Digestive and Liver Disease 2011, 43:862-868.
37. Grainge M.J., West J., Solaymani-Dodaran M., et al. The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study. Alimentary Pharmacology and Therapeutics 2012, 35:730-739.